Skip to main content
NIH funding notice RFA-DK-17-024

Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required)

Closed on December 6, 2018.

Posted
February 15, 2018
Close date
December 6, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $660,368 in first-year total cost, median $660,368.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-9 (M3)]1

Most frequent institutions

  1. JAEB CENTER FOR HEALTH RESEARCH, INC.1
Competing awards under RFA-DK-17-024 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes1R01DK122603-01CHAYTOR, NAOMI SAGEKUDVA, YOGISH C.MILLER, KELLEEPRATLEY, RICHARD ERICKELS, MICHAEL RJAEB CENTER FOR HEALTH RESEARCH, INC., FL$660,368ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.